A Swedish SME is looking for European distributors or agents for their innovative neonatal nutrition decision support software

Nutrition is fundamental for optimal growth and long-term health of preterm babies. Preterm infants have higher nutrient requirements than term infants. One reason for this is that they miss the third trimester of pregnancy which is the intended period of nutrient accumulation and rapid growth. Precise nutrition is crucial for optimal growth of the body, organs and for lifelong quality of life, as early nutritional deficit can cause impaired neurological development. Modern neonatal care has improved the survival rate of extremely preterm infants. These infants are at high risk of malnutrition and growth failure during the first months of hospital care. The Swedish company has its origin within the neonatal field as the software's founder has worked for over 25 years on neonatology and on research on nutrition for premature babies. Based on that knowledge they have developed a state-of-the-art CDSS for tailoring individual neonatal nutrition. Ideal to facilitate decisions regarding nutrition and make the job for medical staff at the clinics more efficient and secure. By tailoring individual nutrition, the software improves the quality of life for the specific patient; saving the clinic time and money through time-efficient nutrition calculations; reducing follow-up costs for the healthcare system by minimizing preventable disabilities; creating a healthier population. For instance, the use of the neonatal nutrition decision support software reduces the risk of complications and long-term disabilities for preterm infants such as ROP (Retinopathy of Prematurity) and BPD (Bronchopulmonary Dysplasia). There are other simpler CDSS on the market that partially accounts for the nutritional intake of the patient. These solutions only account enteral or, alternatively, parenteral nutrition rather than both, and cannot offer the user the true total. This can be problematic as preterm infants, in most cases, go from predominantly parenteral nutrition to predominantly enteral nutrition in a gradually transactional phase. The Swedish company’s software has a significant competitive edge globally as it is the only solution available that accounts for both types of intakes as well as offer an array of additional user-friendly functions, making it state-of-the-art within the field. The software is a standard in Swedish neonatal healthcare and has been scientifically proven to improve nutritional intake and growth. To further grow the company and make their neonatal nutrition decision support software available to hospitals and neonatal clinic around the world they are now looking for distribution or commercial agency agreements with distributors and/or agents within Europe.